Out of hours percutaneous coronary interventions in acute coronary syndromes: long-term outcome

• Published in: Heart (British Cardiac Society) Vol. 92; no. 8; pp. 1157 - 1158
• Main Authors: Berger, A, Meier, J-M, Wasserfallen, J-B, Graf, D, Renders, F, Dascotte, Y, Prudent, V, Eeckhout, E
• Format: Journal Article
• Language: English
• Published: London BMJ Publishing Group Ltd and British Cardiovascular Society 01-08-2006; BMJ; BMJ Publishing Group LTD; BMJ Group
• Subjects: Acute coronary syndromes; After-Hours Care; Aged; Angioplasty, Balloon, Coronary; Biological and medical sciences; CADILLAC; Cardiology. Vascular system; Cardiovascular disease; Controlled Abciximab and Device Investigation to Lower Late angioplasty Complications; Coronary heart disease; Disease-Free Survival; Emergency medical care; Female; Fragmin and Fast Revascularization during Instability in Coronary Artery Disease II; FRISC II; Heart; Heart attacks; Humans; Intervention; Length of Stay; Logistics; MACE; major adverse coronary events; Male; Maximal Individual Therapy in Acute Myocardial Infarction; Medical sciences; MITRA; Mortality; Myocardial Infarction - therapy; Myocardial Revascularization; PCI; percutaneous coronary intervention; Population; Prospective Studies; Scientific Letter; ST segment elevation myocardial infarction; STEMI; Thrombolysis In Myocardial Infarction; Time Factors; TIMI; Treatment Outcome; Prognosis; Angioplasty; Acute; Coronary artery; Instrumentation therapy; Cardiovascular disease; Evolution; Circulatory system; Cardiology; Coronary heart disease; Long term; Phlebology
• ISSN: 1355-6037; 1468-201X
• DOI: 10.1136/hrt.2005.081281

Furthermore, a retrospective analysis of 491 patients from the MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) study reported no in-hospital mortality difference between patients treated from 20 00 to 08 00 and from 08 00 to 20 00 (8.7% v 5.3%, p = 0.238). Since publication of the FRISC II (Fragmin and Fast Revascularization during Instability in Coronary Artery Disease II) study, several reports have confirmed the benefit of the systematic invasive approach for patients with non-STEMI.